Furthermore, a study published in the Journal of Neuroendocrinology has suggested that the ECS is capable of stimulating specific areas of the body involved in metabolism, such as the skeletal muscles and GI tract. This happens due to the presence of anandamide and 2-AG, which are two naturally-occurring compounds in the body that interact with the CB1 and CB2 receptors.
Cannabis is often associated with increased appetite (the munchies) and weight gain. However, this is due to its notorious tetrahydrocannabinol (THC) content. Cannabidiol, or CBD, does not contain THC, so it is less likely to cause you to binge on a whole bag of Doritos. In fact, CBD can do just the opposite. By reducing your appetite, it can help you consume fewer calories and lose excess weight.
CBD oil is good for bodybuilding and muscle growth in the sense that it eases inflammation, helps with muscle recovery, and reduces pain after workouts. This makes it easier for you to increase your muscle mass without putting your body under too much stress. The naturally relaxing and anti-inflammatory effects of CBD help your muscles to recover more quickly.
CBD’s effect on homeostasis is believed to be why those in need of nutrition can experience an appetite increase and those with excess weight can experience an appetite decrease. The reason for this is that CBD is an adaptogen. Referred to by some scientists as “the boy scout molecule” because it always does the right thing in any given situation. The Journal of Psychopharmacology tested this theory on rats in 2012. The researchers wanted to see how three common cannabinoids, including CBN, CBD, and CBG, affected the appetite of the rats. The study concluded that both CBD and CBG worked to reduce the rat’s appetite.
Correcting a calorie excess with a calorie deficit sometimes works for weight loss, but it can be difficult. First of all, reducing calories leaves people feeling hungry, which can be incredibly uncomfortable. Second of all, weight gain can cause changes to hormone levels and balance, metabolic patterns, inflammation status, and balance within the endocannabinoid system.
It’s fair to say that the CBD market is thriving. According to market intelligence company Hemp Business Journal, $130 million worth of products containing the cannabinoid were bought in the U.S. in 2016. And that figure is only set to rise in the years to come, the data analyst believes. Indeed, the source estimates that consumer sales of CBD goods will total an astounding $2.1 billion by 2020 – buoyed, perhaps, by claims that the usage of such products can help alleviate the symptoms of chronic pain, depression and diabetes, to name but a few conditions.